Virological outcomes and genotypic resistance on dolutegravirbased antiretroviral therapy versus standard of care in children and adolescents a secondary analysis of the ODYSSEY trial

dc.article.end-page213en
dc.article.start-page201en
dc.citation.doi10.1016/S2352-3018(24)00155-3en
dc.contributor.authorE Whiteen
dc.contributor.authorC Kityoen
dc.contributor.authorM Spyeren
dc.contributor.authorH Mujuruen
dc.contributor.authorAfaaf Libertyen
dc.contributor.authorHaseena Cassimen
dc.contributor.authorE et alen
dc.date.accessioned2026-04-07T18:41:45Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2352-3018en
dc.identifier.urihttps://hdl.handle.net/10539/48918
dc.journal.titleVirological outcomes and genotypic resistance on dolutegravirbased antiretroviral therapy versus standard of care in children and adolescents a secondary analysis of the ODYSSEY trialen
dc.journal.volume12en
dc.titleVirological outcomes and genotypic resistance on dolutegravirbased antiretroviral therapy versus standard of care in children and adolescents a secondary analysis of the ODYSSEY trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
183.46 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client